Physician

Vipal Soni, M.D.

According to 2025 Medicare claims, Vipal Soni, M.D. (NPI: 1114018173) practices dermatology in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is VIPAL SONI M.D., INC. (NPI: 1962726331; TIN: 27-2105362) and primary practice location at 92647-9998.

Soni's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 959 traditional Medicare patients, billed 12,602 HCPCS/CPT codes, and received $1,857,714 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,039 prescription claims across 504 beneficiaries totaling $127,241 in drug costs, led by Otezla (Apremilast). Open Payments data shows 4 records totaling $202. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $650,782 to $1,857,714. Similarly, Part D prescription costs have risen steadily, from $45,473 to $127,241. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$929K$1.9M2015 Medicare payment: $650,782 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $656,810 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $651,966 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $623,426 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $716,437 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $715,575 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $791,742 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $958,312 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,006,954 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,857,714 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0199,504$650,782
20169759,103$656,810
20178968,387$651,966
20188457,418$623,426
20198888,055$716,437
20208327,869$715,575
20218928,152$791,742
20228899,713$958,312
20239479,773$1,006,954
202495912,602$1,857,714

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$100K$199K2015 Drug cost: $45,473 (USD; Tot_Drug_Cst)2016 Drug cost: $30,155 (USD; Tot_Drug_Cst)2017 Drug cost: $76,067 (USD; Tot_Drug_Cst)2018 Drug cost: $99,526 (USD; Tot_Drug_Cst)2019 Drug cost: $93,801 (USD; Tot_Drug_Cst)2020 Drug cost: $111,494 (USD; Tot_Drug_Cst)2021 Drug cost: $66,783 (USD; Tot_Drug_Cst)2022 Drug cost: $177,912 (USD; Tot_Drug_Cst)2023 Drug cost: $199,397 (USD; Tot_Drug_Cst)2024 Drug cost: $127,241 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015258520$45,473
2016245481$30,155
2017240468$76,067
2018242463$99,526
2019277527$93,801
2020289570$111,494
2021286535$66,783
2022498958$177,912
20235341,044$199,397
20245041,039$127,241

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more291390$100
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more664992$72
17000Destruction of precancer skin growth, 1 growth435568$45
88305Pathology examination of tissue using a microscope, intermediate complexity450942$30
17003Destruction of precancer skin growth, 2-14 growths3712,456$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast15450$73,394
Clobetasol PropionateClobetasol Propionate641,965$3,608
Betamethasone DipropionateBetamethasone Dipropionate511,139$2,717
KetoconazoleKetoconazole1093,218$2,098
FluorouracilFluorouracil301,000$1,996

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$202Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Vipal Soni, M.D.?

Tedicare shows public-source Medicare data for Vipal Soni, M.D. (NPI 1114018173), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vipal Soni, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vipal Soni, M.D.?

Vipal Soni, M.D. is linked to VIPAL SONI M.D., INC. (billing NPI 1962726331) in the available physician profile data.

Does Vipal Soni, M.D. have Open Payments data?

Vipal Soni, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.